Long-Term Effects of ACE Inhibitors in Post-Tuberculosis Emphysema |
Kim, Myung-A
(Department of Internal Medicine, Seoul Metropolitan Boramae Medical Center, Seoul National University College of Medicine)
Lee, Chang-Hoon (Department of Internal Medicine, Seoul Metropolitan Boramae Medical Center, Seoul National University College of Medicine) Kim, Deog-Kyeom (Department of Internal Medicine, Seoul Metropolitan Boramae Medical Center, Seoul National University College of Medicine) Chung, Hee-Soon (Department of Internal Medicine, Seoul Metropolitan Boramae Medical Center, Seoul National University College of Medicine) |
1 | Busquets X, MacFarlane NG, Heine-Suner D, Morla M, Torres-Juan L, Iglesias A, et al. Angiotensin-converting- enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007;2:329-34. |
2 | Barnes PJ. Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 2008;5:857-64. DOI ScienceOn |
3 | Matthay RA, Niederman MS, Wiedemann HP. Cardiovascular- pulmonary interaction in chronic obstructive pulmonary disease with special reference to the pathogenesis and management of cor pulmonale. Med Clin North Am 1990;74:571-618. DOI |
4 | Willenheimer R, Rydberg E, Oberg L, Juul-Moller S, Erhardt L. ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function. Eur Heart J 1999;20:1647-56. DOI ScienceOn |
5 | van Suylen RJ, Smits JF, Daemen MJ. Pulmonary artery remodeling differs in hypoxia- and monocrotaline- induced pulmonary hypertension. Am J Respir Crit Care Med 1998;157:1423-8. DOI ScienceOn |
6 | Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. Angiotensin II and inflammation: the effect of angiotensin- converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens 2007;21:20-7. DOI ScienceOn |
7 | Birath G, Caro J, Malmberg R, Simonsson BG. Airways obstruction in pulmonary tuberculosis. Scand J Respir Dis 1966;47:27-36. |
8 | Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management. Chest 1991;99:715-23. DOI ScienceOn |
9 | Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991;144:1202-18. DOI ScienceOn |
10 | Poppius H. Airway obstruction in pulmonary tuberculosis. Scand J Respir Dis Suppl 1968;65:165-9. |
11 | Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis 1971;103:625-40. |
12 | Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Washington: Medical Communications Resources; 2009. |
13 | Rubin LJ. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension. Clin Chest Med 1983;4:309-19. |
14 | Matthay RA, Arroliga AC, Wiedemann HP, Schulman DS, Mahler DA. Right ventricular function at rest and during exercise in chronic obstructive pulmonary disease. Chest 1992;101:255S-62S. DOI |
15 | Nong Z, Stassen JM, Moons L, Collen D, Janssens S. Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling. Circulation 1996;94: 1941-7. DOI ScienceOn |
16 | Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998;113:576-83. DOI ScienceOn |
17 | Schulman DS, Matthay RA. The right ventricle in pulmonary disease. Cardiol Clin 1992;10:111-35. |
18 | Kim MA, Kim SH, Zo JH, Hwangbo B, Lee JH, Chung HS. Right heart dysfunction in post-tuberculosis emphysema. Int J Tuberc Lung Dis 2004;8:1120-6. |
19 | Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006;47:2554-60. DOI ScienceOn |
20 | Cazzola M, Matera MG, Rogliani P, Page C. Treating systemic effects of COPD. Trends Pharmacol Sci 2007; 28:544-50. DOI ScienceOn |
21 | Mortensen EM, Copeland LA, Pugh MJ, Restrepo MI, de Molina RM, Nakashima B, et al. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res 2009;10:45. DOI ScienceOn |
22 | Schlueter DP, Immekus J, Stead WW. Relationship between maximal inspiratory pressure and total lung capacity (coefficient of retraction) in normal subjects and in patients with emphysema, asthma, and diffuse pulmonary infiltration. Am Rev Respir Dis 1967;96:656-65. |